4
Changes in Ownership
Aligos Therapeutics, Inc. Filed Acc 0001567619-20-018004
Quan Lucinda Y. acquired 9,258 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-10-20 | Conversion : show line 1 in the form | +6,835 | 6,835 | I |
| 2020-10-20 | Conversion : show line 2 in the form | +1,697 | 8,532 | I |
| 2020-10-20 | Conversion : show line 3 in the form | +726 | 9,258 | I |
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-10-20 | Conversion : show line 4 in the form Series A Preferred Stock | −6,835 | 0 | I |
| 2020-10-20 | Conversion : show line 5 in the form Series B-1 Preferred Stock | −1,697 | 0 | I |
| 2020-10-20 | Conversion : show line 6 in the form Series B-2 Preferred Stock | −726 | 0 | I |
Loading xslF345X03/doc1.xml…